| scholarly article | Q13442814 |
| P50 | author | Penny Asbell | Q43109114 |
| P2093 | author name string | Dongmei Chen | |
| Seth P Epstein | |||
| P2860 | cites work | Wound healing. The effects of topical antimicrobial agents | Q28328452 |
| Quaternary ammoniums and other preservatives' contribution in oxidative stress and apoptosis on Chang conjunctival cells. | Q32061868 | ||
| Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study. | Q33202369 | ||
| Side effects of antiglaucomatous drugs on the ocular surface | Q33573168 | ||
| Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells | Q34218606 | ||
| Effects of common ophthalmic preservatives on ocular health | Q34488195 | ||
| Hydrogen peroxide poisoning | Q35857771 | ||
| Pharmacological consequences of oxidative stress in ocular tissues | Q36213282 | ||
| Comparative study on the cytotoxic effects of benzalkonium chloride on the Wong-Kilbourne derivative of Chang conjunctival and IOBA-NHC cell lines | Q36499358 | ||
| Cytotoxicity of mercurial preservatives in cell culture | Q36645577 | ||
| Potential clinical applications of C-reactive protein | Q37815158 | ||
| Multivariate tests for multiple endpoints in clinical trials | Q40478068 | ||
| A comparison of the effects of ocular preservatives on mammalian and microbial ATP and glutathione levels | Q40509995 | ||
| Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B. | Q40918234 | ||
| Immortalized human corneal epithelial cells for ocular toxicity and inflammation studies | Q40955464 | ||
| Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. | Q40968901 | ||
| An in vitro method which assesses corneal epithelial toxicity due to antineoplastic, preservative and antimicrobial agents | Q41257838 | ||
| Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease | Q43723395 | ||
| An in vivo comparison of topical agents on wound repair | Q43792521 | ||
| Depression of liver drug metabolism and increase in plasma fibrinogen by interleukin 1 and tumor necrosis factor: a comparison with lymphotoxin and interferon | Q43889372 | ||
| Cellular Immunity and the Inflammatory Response | Q44129953 | ||
| Quantitative cytotoxicity of preservatives evaluated in cell culture with Chang's human conjunctival cells--effect of temperature on cytotoxicity | Q44568980 | ||
| Corneal and conjunctival changes caused by commonly used glaucoma medications | Q44954267 | ||
| Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye. | Q45950875 | ||
| Cytotoxicity to cultured human keratinocytes of topical antimicrobial agents | Q46142097 | ||
| Inhibition of wound contraction by topical antimicrobials. | Q52516157 | ||
| Analysis of inflammatory cytokines in the tears of dry eye patients. | Q54467014 | ||
| Effect of the ophthalmic preservative thimerosal on rabbit and human corneal endothelium | Q67556429 | ||
| Sjögren's syndrome: cytokine and Epstein-Barr viral gene expression within the conjunctival epithelium | Q72120476 | ||
| Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca | Q72993423 | ||
| Antimicrobial effect of hydrogen peroxide and lactic acid in the mouth | Q76489625 | ||
| Elevated tear interleukin-6 levels in patients with Sjögren syndrome | Q77689430 | ||
| Effects of topical antiglaucoma medications on the ocular surface | Q79387442 | ||
| [Tumor necrosis factor-alpha in tears of patients with Sjögren syndrome] | Q80181976 | ||
| Strain-related cytokine profiles on the murine ocular surface in response to desiccating stress | Q80382639 | ||
| Distribution of conjunctival HLA-DR expression and the pathogenesis of damage in early dry eyes | Q81357274 | ||
| The unveiling of hidden T-cell determinants of a native antigen by defined mediators of inflammation: implications for the pathogenesis of autoimmunity | Q83204973 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| biomarker | Q864574 | ||
| P304 | page(s) | 415-424 | |
| P577 | publication date | 2009-10-01 | |
| P1433 | published in | Journal of Ocular Pharmacology and Therapeutics | Q15755845 |
| P1476 | title | Evaluation of biomarkers of inflammation in response to benzalkonium chloride on corneal and conjunctival epithelial cells | |
| P478 | volume | 25 |
| Q37729041 | A Comparison of the Effects of Benzalkonium Chloride on Ocular Surfaces between C57BL/6 and BALB/c Mice. |
| Q41668980 | Analysis of the effects of preservative-free tafluprost on the tear proteome |
| Q41125727 | Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits |
| Q41717624 | Balancing antimicrobial efficacy and toxicity of currently available topical ophthalmic preservatives. |
| Q37905991 | Benzalkonium chloride in glaucoma medications. |
| Q37697869 | Bimatoprost 0.01% vs bimatoprost 0.03%: a 12-month prospective trial of clinical and in vivo confocal microscopy in glaucoma patients |
| Q39332349 | CX3CL1 expression in the conjunctiva is involved in immune cell trafficking during toxic ocular surface inflammation. |
| Q39171184 | Cell viability score (CVS) as a good indicator of critical concentration of benzalkonium chloride for toxicity in cultured ocular surface cell lines |
| Q35555771 | Challenges in the clinical measurement of ocular surface disease in glaucoma patients |
| Q36443965 | Comparison of the Efficacy of Fluorometholone With and Without Benzalkonium Chloride in Ocular Surface Disease. |
| Q87431284 | Confocal microscopy of epithelial and langerhans cells of the cornea in patients using travoprost drops containing two different preservatives |
| Q30389442 | Cytoprotective effect of lacritin on human corneal epithelial cells exposed to benzalkonium chloride in vitro |
| Q34672610 | Determining the Depth of Injury in Bioengineered Tissue Models of Cornea and Conjunctiva for the Prediction of All Three Ocular GHS Categories |
| Q95298719 | Development of an enzyme-linked immunosorbent assay for Keap1-Nrf2 interaction inhibitors identification |
| Q36908446 | Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma |
| Q31132977 | Effects of benzalkonium chloride on THP-1 differentiated macrophages in vitro. |
| Q48270719 | Effects of ophthalmic disease on concentrations of plasma fibrinogen and serum amyloid A in the horse |
| Q42769999 | Effects of timolol-related ophthalmic solutions on cultured human conjunctival cells |
| Q34393007 | Efficacy, safety, and tolerability of travoprost 0.004% BAK-free versus prior treatment with latanoprost 0.005% in Japanese patients |
| Q42704847 | Ex vivo corneal epithelial wound healing following exposure to ophthalmic nonsteroidal anti-inflammatory drugs |
| Q44666122 | Human corneal epithelial cell shedding and fluorescein staining in response to silicone hydrogel lenses and contact lens disinfecting solutions |
| Q84607779 | Human gingiva is another site of C‐reactive protein formation |
| Q39221538 | Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits |
| Q36898923 | In vitro and in vivo experimental studies on trabecular meshwork degeneration induced by benzalkonium chloride (an American Ophthalmological Society thesis). |
| Q42975877 | In vitro effects of preserved and unpreserved anti-allergic drugs on human corneal epithelial cells. |
| Q42617474 | In vivo confocal microscopy of conjunctiva in preservative-free timolol 0.1% gel formulation therapy for glaucoma. |
| Q38994594 | Increased extracellular matrix metalloproteinase inducer (EMMPRIN) expression in the conjunctival epithelium exposed to antiglaucoma treatments |
| Q93046434 | Meibomian gland dropout rate as a method to assess meibomian gland morphologic changes during use of preservative-containing or preservative-free topical prostaglandin analogues |
| Q58587618 | New Classes of Polycationic Compounds as Preservatives for Ophthalmic Formulations |
| Q35382551 | Ocular tropism of influenza A viruses: identification of H7 subtype-specific host responses in human respiratory and ocular cells |
| Q37929746 | Ophthalmic preservatives: focus on polyquaternium-1. |
| Q39791012 | Patient adherence and persistence with topical ocular hypotensive therapy in real-world practice: a comparison of bimatoprost 0.01% and travoprost Z 0.004% ophthalmic solutions |
| Q38981502 | Preliminary studies on validation of calu-3 cell line as a model for screening respiratory mucosa irritation and toxicity |
| Q27009083 | Preservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye drops |
| Q35075328 | Semaphorin 3A controls allergic and inflammatory responses in experimental allergic conjunctivitis |
| Q52584045 | Tacrolimus Loaded PEG-Cholecalciferol Based Micelles for Treatment of Ocular Inflammation. |
| Q36240200 | The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery. |
| Q92543217 | The impact of topical intraocular pressure lowering medications on the ocular surface of glaucoma patients: A review |
| Q36099684 | Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model. |
Search more.